Becoming a professional soccer player despite profound hearing loss

Simon Ollert

From a young age Simon Ollert from southern Germany knew what his life dream would be: to become a professional in his favorite sport.

“My story shows just what you can achieve despite hearing loss. I have a great life and don’t feel restricted in the slightest,” says Simon. He is looking to the future with confidence, and adds “I have always set myself goals and always achieved them. If you really want something, you’ll get it.”

Sonova has produced a short film based on the young football player’s story. The film called “Life without Limitations” has received a gold award at the 2016 International Commercial Film Festival – the largest competition for commercial films from the German-speaking world.

Spanish audiology experts stress dangers of sound amplification apps
Spanish audiology experts stress dangers of sound amplification apps

 

apps

© Chainarong Prasertthal - iStock

Prolonged use of sound amplification apps such as Google's Sound Amplifier may cause hearing problems instead of easing them, warns the National Association of Audiologists of Spain (ANA).

Noise from Rugby World Cup tourism worries councils in Japan
Noise from Rugby World Cup tourism worries councils in Japan

 

noise

© Wavebreakmedia - iStock

There will be a massive roar in Japanese stadiums hosting the Rugby World Cup, which starts on Friday September 20, but it will barely compete with the street noise in the country with the world's worst acoustic pollution problem.

Apple conducts major hearing study as part of growing "democratisation" of research
Apple conducts major hearing study as part of growing

 

data

© Apple

In a move that Apple claims will allow customers to contribute to medical discoveries, the phone and computer giant is to conduct three large-scale health studies, one of them into the impact of everyday sound exposure on hearing.

New Oticon Sales VP has followed a trail of beauty
New Oticon Sales VP has followed a trail of beauty

 

appointments

© Oticon

Oticon has appointed a new Vice President of Sales, Roger Peterson, who will work from the Danish multinational's US head office in Somerset, New Jersey, reporting to Oticon President Gary Rosenblum.

UK NHS Q2 hearing aid sales drop as a result of Brexit stockpiling
UK NHS Q2 hearing aid sales drop as a result of Brexit stockpiling

 

brexit

© BrasilNut1 - iStock

A seesaw in hearing aid sales is the only clear market indicator so far of any effect of the Brexit process in the UK and Ireland, but there is a simple explanation behind the latest figures.

"Cybercrime" collapses Demant's IT infrastructure

 

hacking

©scyther5 -iStock

A critical "cybercrime" incident brought down the IT system of the multinational hearing technology group, Demant, on Tuesday (September 3).

Hearing is enhanced by vagus nerve stimulation paired with repetitive sounds
Hearing is enhanced by vagus nerve stimulation paired with repetitive sounds

 

brain

© fotojog - iStock

Potential therapeutic benefits for a range of conditions including tinnitus have been glimpsed thanks to newly published research involving vagus nerve stimulation (VNS) in rats.

Company Directory

New products

The New Oticon Xceed The New Oticon Xceed

 

©Oticon

Oticon completes its hearing aid portfolio with the launch of the Oticon Xceed and Oticon Xceed Play power hearing aids for profound hearing loss. Hearing care professionals now have access to the most updated hearing aid portfolio on the market with a complete range of hearing aids, all featuring the Velox S platform.

 [ ... ]

Phonak Marvel 2.0 with RogerDirect™ available in all Marvel hearing aids

 
©Phonak

Phonak, the world’s leading hearing aid provider, has launched Marvel 2.0, "the next generation of Marvel technology developed to give hearing aid wearers even more hearing performance, more connectivity and more choice".

 [ ... ]

FDA clearance for new Ponto 4FDA clearance for new Ponto 4

CI

Oticon Medical has announced that it has obtained 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market the new Ponto 4 [ ... ]